Navigating Cancer
Welcome to Navigating Cancer
- Navigating Cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD142—213m (Dealroom.co estimates Sep 2019.)
Seattle Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.2m | Series A | |
N/A | $3.0m | Series B | |
$2.3m | Debt | ||
$10.0m | Series C | ||
$12.0m | Late VC | ||
$26.0m | Series D | ||
Total Funding | CAD72.5m |
Related Content
Recent News about Navigating Cancer
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.